Diabetes in the UAE Industry Platform
This platform into an analysis of the diabetes market and the utilization of advanced technology in managing individuals with diabetes, with a specific focus on the UAE. Despite extensive national campaigns aimed at raising awareness about the detrimental effects of fast-food consumption and sedentary lifestyles, the Arab population still faces a heightened risk of metabolic disorders.
During the last decade the UAE demonstrated one of the highest value of undiagnosed diabetes, as well as the high prevalence for the disease in adults. The escalating prevalence of diabetes in the UAE, driven by changing lifestyles, poses an economic challenge. Projections indicate that diabetes-related costs in the UAE alone are expected to increase, reaching 24.7 billion USD by 2035.
Within this platform, we conducted a comprehensive examination of the genetic factors contributing to diabetes in Arab populations. It also covers an analysis of the healthcare market and the key market players in the UAE.
Diabetes in UAE Industry is a pioneering platform where the frontiers of advanced biotechnology converge with innovative solutions for diabetes, seamlessly connecting you with esteemed investors, reputable institutions, and progressive research and development centers.
With innovative therapies, state-of-the-art wearable technologies, AI-driven monitoring systems, and personalized precision medicine for diabetes, the Diabetes Platform is revolutionizing the diabetes care landscape in the UAE.
UAE Life Sciences Ecosystem
The UAE Life Sciences Ecosystem IT Platform is a unique collaborative initiative created by Deep Knowledge Group and Aging Analytics Agency. As a central hub for resources, information, and interaction, our platform serves as a comprehensive guide to the thriving UAE life sciences ecosystem.
Diabetes in the UAE Leaders
The field of diabetes is led by a diverse group of experts who are at the forefront of innovation. These professionals include researchers, data scientists, endocrinologists, and technologists who are dedicated to address the complex challenges associated with diabetes management in the UAE region. Their expertise and collaborative efforts are instrumental in developing systems that optimize diabetes care.
AI in BioMed
A comprehensive platform AI in BioMed sheds light on the developing nexus between artificial intelligence and biotechnology. Access to ground-breaking AI frameworks, powerful investors, business leaders, well-known organizations, and state-of-the-art research facilities are all available through this complex center, which addresses a range of subjects from biomarkers and drug discovery to neurotech and space medicine.
Global AI in Drug Discovery Platform
Analytics platform to explore how AI is revolutionizing drug discovery globally. You will gain access to our interactive databases for AI in drug discovery, containing filterable, searchable, interactive mindmaps and profiles of 800 companies, 1,900 investors, 90 corporations, 50 hubs, and 100 leaders.
Explore Solutions
Diabetes Industry Global Dashboard
Aging Analytics Agensy has engineered an advanced analytical dashboard capable of defining, analysing, and predicting trends in the Diabetes industry, and the DeepTech technologies powering it.
The Dashboard provides professional users with comparative analytical capabilities, including interactive, searchable and filterable databases of companies, investors and funding rounds, as well as Automated SWOT Analysis and AI-Driven Smart-Matching facilities.
Aging Analytics Agency – Powered by Deep Knowledge Group
Aging Analytics Agency is a subsidiary of Deep Knowledge Group, a data-driven consortium of commercial and non-profit organizations active on many fronts in the realm of DeepTech and Frontier Technologies (AI, Longevity, BioTech, Pharma, FinTech, GovTech, SpaceTech, FemTech, Data Science, InvestTech), ranging from scientific research to investment, entrepreneurship, analytics, consulting, media, philanthropy and more.